Page last updated: 2024-09-03

1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and Hypertension

1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine has been researched along with Hypertension in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Jia, H; Mu, JJ; Wang, Y1
Sookaromdee, P; Wiwanitkit, V1
Chang, J; Chen, C; Chen, FY; Chu, C; Du, MF; Gao, K; Gao, WH; Guan, YJ; Hu, GL; Hu, JW; Jia, H; Li, CH; Liao, YY; Ma, Q; Mu, JJ; Niu, ZJ; Sun, Y; Wang, D; Wang, KK; Wang, X; Wang, Y; Yan, Y; Yang, TL; Yao, S; Zhang, J; Zhang, X; Zhang, XY; Zhou, HW; Zou, T1

Other Studies

3 other study(ies) available for 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and Hypertension

ArticleYear
Reply to 'Plasma PAPP-A2 and genetic variations with hypertension'.
    Journal of hypertension, 2022, 04-01, Volume: 40, Issue:4

    Topics: Genetic Variation; Humans; Hypertension; Piperazines

2022
Plasma PAPP-A2 and genetic variations with hypertension.
    Journal of hypertension, 2022, 04-01, Volume: 40, Issue:4

    Topics: Genetic Variation; Humans; Hypertension; Piperazines

2022
Associations of plasma PAPP-A2 and genetic variations with salt sensitivity, blood pressure changes and hypertension incidence in Chinese adults.
    Journal of hypertension, 2021, 09-01, Volume: 39, Issue:9

    Topics: Adult; Animals; Blood Pressure; Blood Proteins; China; Female; Humans; Hypertension; Incidence; Piperazines; Polymorphism, Single Nucleotide; Pregnancy; Rats; Sodium Chloride, Dietary

2021